X0306 4 2022-04-27 0000887359 Vericel Corp VCEL 0001220363 ZERBE ROBERT L MD C/O VERICEL CORPORATION 64 SIDNEY STREET CAMBRIDGE MA 02139 true false false false Common Stock 2022-04-27 4 M false 2600 A 4350 D Restricted Stock Unit 2022-04-27 4 M false 2600 D Common Stock 2600 0 D Restricted Stock Unit 2022-04-27 4 A false 2600 0 A Common Stock 2600 2600 D Stock Option (right to buy) 31.99 2022-04-27 4 A false 6500 0 A 2032-04-27 Common Stock 6500 6500 D The Restricted Stock Units (RSUs) converted to phantom stock units and are deferred under the Company's Non-Employee Directors' Deferred Compensation Program. The units will be payable only in shares of Common Stock after the end of the Reporting Person's service on the Company's Board of Directors. Upon the vesting of RSUs granted to the Reporting Person on April 28, 2021, the Reporting Person deferred the receipt of 2,600 shares of Common Stock and instead received 2,600 shares of Phantom Stock pursuant to the Company's Non-Employee Directors' Deferred Compensation Program. Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. These RSUs vest 100% on the earlier of April 28, 2022 or the date of the first Annual Meeting of Stockholders following April 28, 2021. The first Annual Meeting of Stockholders occurred on April 27, 2022. No expiration date for this type of award. These RSUs vest 100% on the earlier of April 27, 2023 or the date of the first Annual Meeting of Stockholders following April 27, 2022. Vested shares will be delivered to the Reporting Person following termination of service on the Company's Board of Directors. The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. /s/ Sean Flynn, as Attorney-in-Fact for Robert Zerbe 2022-04-29